Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ozempic (semaglutide)
Biotech
Chinese insulin maker’s GLP-1 bests Ozempic in ph. 2, company says
Biweekly GZR18 injections led to a maximum weight loss of almost 12 pounds at 24 weeks, compared to just over seven pounds for Novo's semaglutide.
Darren Incorvaia
Oct 15, 2024 11:12am
UPDATE: Lilly-backed metabolic disease biotech files IPO
Sep 4, 2024 10:23am
GLP-1 liraglutide reduces cognitive decline in Alzheimer's
Jul 30, 2024 1:29pm
A look at the R&D landscape in obesity, led by GLP-1s
Mar 19, 2024 8:00am
Vivani's exenatide implant boosts weight loss as well as Wegovy
Mar 1, 2024 10:00am
Novo Nordisk unveils new US hub as R&D investments soar
Feb 29, 2024 5:00am
